Europäische Union - Deutsch - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningitis, meningokokken - impfstoffe - nimenrix ist indiziert zur aktiven immunisierung von personen im alter von 6 wochen gegen invasive meningokokken-erkrankungen, die durch neisseria meningitidis gruppe a, c, w-135 und y verursacht werden.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1, polysaccharida streptococci pneumoniae typus 2, polysaccharida streptococci pneumoniae typus 3, polysaccharida streptococci pneumoniae typus 4, polysaccharida streptococci pneumoniae typus 5, polysaccharida streptococci pneumoniae typus 6b, polysaccharida streptococci pneumoniae typus 7f, polysaccharida streptococci pneumoniae typus 8, polysaccharida streptococci pneumoniae typus 9n, polysaccharida streptococci pneumoniae typus 9v, polysaccharida streptococci - injektionslösung in einer durchstechflasche - polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 2 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6b 25 µg, polysaccharida streptococci pneumoniae typus 7f 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9n 25 µg, polysaccharida streptococci pneumoniae typus 9v 25 µg, polysaccharida streptococci pneumoniae typus 10a 25 µg, polysaccharida streptococci pneumoniae typus 11a 25 µg, polysaccharida streptococci pneumoniae typus 12f 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15b 25 µg, polysaccharida streptococci pneumoniae typus 17f 25 µg, polysaccharida streptococci pneumoniae typus 18c 25 µg, polysaccharida streptococci pneumoniae typus 19a 25 µg, polysaccharida streptococci pneum - aktive immunisierung gegen pneumokokken-infektionen, insbesondere pneumonien, ab dem vollendeten 2. lebensjahr - impfstoffe

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1, polysaccharida streptococci pneumoniae typus 3, polysaccharida streptococci pneumoniae typus 4, polysaccharida streptococci pneumoniae typus 5, polysaccharida streptococci pneumoniae typus 6b, polysaccharida streptococci pneumoniae typus 7f, polysaccharida streptococci pneumoniae typus 8, polysaccharida streptococci pneumoniae typus 9n, polysaccharida streptococci pneumoniae typus 9v, polysaccharida streptococci pneumoniae typus 10a, polysaccharida streptococci pneumoniae typus 11a, polysaccharida streptococci pneumoniae typus 12f, polysaccharida streptococci pneumoniae typus 14, polysaccharida streptococci pneumoniae typus 15b, polysaccharida streptococci pneumoniae typus 17f, polysaccharida streptococci pneumoniae typus 20, polysaccharida streptococci pneumoniae typus 22f, polysaccharida streptococci pneumoniae typus 23f, polysaccharida streptococci pneumoniae typus 33f - injektionslösung in einer fertigspritze - polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6b 25 µg, polysaccharida streptococci pneumoniae typus 7f 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9n 25 µg, polysaccharida streptococci pneumoniae typus 9v 25 µg, polysaccharida streptococci pneumoniae typus 10a 25 µg, polysaccharida streptococci pneumoniae typus 11a 25 µg, polysaccharida streptococci pneumoniae typus 12f 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15b 25 µg, polysaccharida streptococci pneumoniae typus 17f 25 µg, polysaccharida streptococci pneumoniae typus 20 25 µg, polysaccharida streptococci pneumoniae typus 22f 25 µg, polysaccharida streptococci pneumoniae typus 23f 25 µg, polysaccharida streptococci pneumoniae typus 33f 25 µg, natrii chloridum corresp. natrium 1.8 mg, phenolum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - aktive immunisierung gegen pneumokokken-infektionen, insbesondere pneumonien, ab dem vollendeten 2. lebensjahr - impfstoffe

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

emra-med arzneimittel gmbh (3263935) - streptococcus pneumoniae polysaccharid-gemisch 2 bestehend aus 23 kapseltypen: dänische nomenklatur: 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f, 33f. - injektionslösung in einer fertigspritze - streptococcus pneumoniae polysaccharid-gemisch 2 bestehend aus 23 kapseltypen: dänische nomenklatur: 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f, 33f. (31414) mikrogramm

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1, polysaccharida streptococci pneumoniae typus 2, polysaccharida streptococci pneumoniae typus 3, polysaccharida streptococci pneumoniae typus 4, polysaccharida streptococci pneumoniae typus 5, polysaccharida streptococci pneumoniae typus 6b, polysaccharida streptococci pneumoniae typus 7f, polysaccharida streptococci pneumoniae typus 8, polysaccharida streptococci pneumoniae typus 9n, polysaccharida streptococci pneumoniae typus 9v, polysaccharida streptococci - injektionslösung in einer durchstechflasche - polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 2 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6b 25 µg, polysaccharida streptococci pneumoniae typus 7f 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9n 25 µg, polysaccharida streptococci pneumoniae typus 9v 25 µg, polysaccharida streptococci pneumoniae typus 10a 25 µg, polysaccharida streptococci pneumoniae typus 11a 25 µg, polysaccharida streptococci pneumoniae typus 12f 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15b 25 µg, polysaccharida streptococci pneumoniae typus 17f 25 µg, polysaccharida streptococci pneumoniae typus 18c 25 µg, polysaccharida streptococci pneumoniae typus 19a 25 µg, polysaccharida streptococci pneum - aktive immunisierung gegen pneumokokken-infektionen, insbesondere pneumonien, ab dem vollendeten 2. lebensjahr - impfstoffe

Europäische Union - Deutsch - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 22f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197, polysaccharida streptococci pneumoniae typus 33f conjugata cum proteino corynebacteriae diphtheriae crm 197 - injektionssuspension - polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 6a conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 6b conjugata cum proteino corynebacteriae diphtheriae crm 197 4 µg et polysaccharida streptococci pneumoniae typus 7f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 9v conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 18c conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 19a conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 19f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 22f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 23f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg et polysaccharida streptococci pneumoniae typus 33f conjugata cum proteino corynebacteriae diphtheriae crm 197 2 µg corresp. polysaccharida 32 µg et proteinum corynebacteriae diphtheriae crm 197 ca. 30 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.77 mg, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen pneumokokken-infektionen der serotypen 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 22f, 23f, 33f - impfstoffe

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

nuron biotech bv - corynebacterium diphtheriae (auszug, produkte); neisseria meningitidis (auszug, produkte) - meningokokkus c, gerein

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kohlpharma gmbh (3216120) - meningokokken-gruppe-c-oligosaccharid-diphtherie-crm197-protein-konjugat - injektionssuspension in einer fertigspritze - teil 1 - injektionssuspension in einer fertigspritze; meningokokken-gruppe-c-oligosaccharid-diphtherie-crm197-protein-konjugat (30996) mikrogramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

eurimpharm arzneimittel gmbh (8050167) - meningokokken-gruppe-c-oligosaccharid-diphtherie-crm197-protein-konjugat - injektionssuspension in einer fertigspritze - teil 1 - injektionssuspension in einer fertigspritze; meningokokken-gruppe-c-oligosaccharid-diphtherie-crm197-protein-konjugat (30996) mikrogramm